Both in Pharmaceuticals
Arcus Biosciences vs MBX Biosciences
Over the past year RCUS returned −2.5% and MBX returned +203.7%; their daily moves had a correlation of 0.30.
RCUS −2.5% MBX +203.7%Growth of $1, one year, split-adjusted
| Metric | RCUS | MBX |
|---|---|---|
| Price | $18.14 | $52.97 |
| Market cap | $2.31B | $2.55B |
| Today | +2.14% | +5.33% |
| 1 month | −27.5% | −7.9% |
| 6 months | −26.9% | +82.4% |
| Year to date | −23.9% | +67.9% |
| 1 year | +4.8% | +211.6% |
| Revenue growth (YoY) | −74.4% | — |
| Gross margin | 100.0% | — |
| Net margin | −222.0% | — |
| P/E (TTM) | — | — |
| Price / sales | 19.7× | — |
| Net cash | $601.0M | — |
| Dividend yield | — | — |
| Volatility (60d) | 63.8% | 51.7% |
| Short % of float | 13.6% | 15.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).